CardiaTec Secures €5.8 Million in Seed Funding
CardiaTec, a techbio company decoding the biology behind cardiovascular disease, has announced securing €5.8 million in seed funding. The new funds will allow CardiaTec to expand its platform and progress proprietary drug targets to the preclinical stage. The round was led by Montage Ventures, with participation from other investors, such as Continuum Health Ventures and




